Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00002832
Status:
COMPLETED
Last Update Posted:
2012-07-30
First Post:
1999-11-01
Brief Title:
Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia Myelodysplastic Syndrome or Chronic Myelogenous Leukemia
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelodysplastic Syndromes |
| Leukemia |
Keywords:
| Name | View |
|---|---|
| childhood myelodysplastic syndromes | View |
| Decitabine | View |
| Dacogen | View |
| Filgrastim | View |
| G-CSF | View |
| Neupogen | View |
| Cyclosporine | View |
| Sandimmune | View |
| CYA | View |
| Cyclosporin A | View |
| Peripheral blood stem cells | View |
| PBSC | View |
| Allogeneic bone marrow transplantation | View |
| recurrent childhood acute lymphoblastic leukemia | View |
| recurrent childhood acute myeloid leukemia | View |
| recurrent adult acute myeloid leukemia | View |
| recurrent adult acute lymphoblastic leukemia | View |
| accelerated phase chronic myelogenous leukemia | View |
| blastic phase chronic myelogenous leukemia | View |
| previously treated myelodysplastic syndromes | View |